ArticleFrontiers in molecular biosciences2025
An exploratory study of urinary proteome in trigeminal neuralgia.
Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploratory Research on the Urine Proteome in Patients With Diabetic Peripheral Neuropathy.International journal of endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Trigeminal neuralgia (TN) is a neurological disorder characterized by severe pain and a complex pathogenesis. This condition seriously affects patients' quality of life. The analysis of urinary proteomics has shown great potential in disease research. Objective: The aim of this study is to explore the diagnostic and therapeutic value of urine proteomics in TN. Method: The urine of 10 cases of TN and 11 healthy individuals were studied using liquid chromatography-mass spectrometry (LC-MS) proteomics technology. Group analysis and one to many individual analysis strategies were used in quantitative analysis. Result: A total of 2,620 proteins were identified in the group analysis, and 1,883 of them were quantifiable. Most specimens in each group were distinguishable through clustering analysis of the urinary proteome. Significant enrichment was observed in biological processes such as immune response-regulating signaling pathway, regulation of complement activation, natural killer cell inhibitory signaling pathway, and cytoplasmic translation, as well as in KEGG pathways including antigen processing and presentation, and complement and coagulation cascades. Individual analysis revealed a higher number of significantly different proteins between patients, with seven proteins identified in at least nine patients. Conclusion: The urinary proteome provided molecular characteristics of urinary proteins in patients. It described the changes that occur in the patient's body. The strong enrichment of immune response pathways may be linked to disease onset, suggesting new avenues for immune-based treatments, and the significant differential proteins could become potential disease markers for diagnosis and treatment evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.